Voliotis Dimitris

SVP, Clinical Development at ZNTL

Sold, on record
$1.9M
Dollars the filings state
Form 4 sales
2
Latest Feb 14, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ZNTLZentalis Pharmaceuticals, Inc.SVP, Clinical Development

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ZNTLUnusual
    Jan 20 2022

    Sold 30,000 shares at $61.36 ($1.8M)

    Voliotis Dimitris, SVP, Clinical Development

    Sold 82.8% of holdings ($2.2M position)6,250 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ZNTLPlan not stated
    Feb 14 +25 days

    Sold 601 shares at $50.23 ($30k)

    Voliotis Dimitris, SVP, Clinical Development

    Sold 3.6% of holdings ($833k position)15,978 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Voliotis Dimitris
Source
Feb 14, 2022ZNTLSVP, Clinical DevelopmentForm 4 sale601$30k3.6%Plan not statedSEC
Jan 20, 2022ZNTLSVP, Clinical DevelopmentForm 4 sale30,000$1.8M82.8%UnusualSEC